Published in Circ Arrhythm Electrophysiol on April 30, 2008
Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation (2012) 2.58
Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest (2011) 2.38
Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm (2008) 1.72
Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res (2014) 1.68
Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest (2011) 1.68
Small-conductance calcium-activated potassium channel and recurrent ventricular fibrillation in failing rabbit ventricles. Circ Res (2011) 1.66
Novel molecular targets for atrial fibrillation therapy. Nat Rev Drug Discov (2012) 1.42
Heterogeneous upregulation of apamin-sensitive potassium currents in failing human ventricles. J Am Heart Assoc (2013) 1.24
Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.21
Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. J Am Coll Cardiol (2013) 1.21
Atrial fibrillation in congestive heart failure. Heart Fail Clin (2010) 1.07
Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res (2009) 1.05
The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications. Cardiovasc Res (2010) 1.05
Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation. Circ Res (2014) 0.97
Genetics of atrial fibrillation: from families to genomes. J Hum Genet (2015) 0.96
Criticality in intracellular calcium signaling in cardiac myocytes. Biophys J (2012) 0.95
Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Ther (2011) 0.94
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm (2016) 0.94
Decreased sarcolipin protein expression and enhanced sarco(endo)plasmic reticulum Ca2+ uptake in human atrial fibrillation. Biochem Biophys Res Commun (2011) 0.94
Calcium-voltage coupling in the genesis of early and delayed afterdepolarizations in cardiac myocytes. Biophys J (2015) 0.94
Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. J Clin Invest (2014) 0.93
Mechanisms of ventricular arrhythmias: from molecular fluctuations to electrical turbulence. Annu Rev Physiol (2014) 0.92
Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.92
Spontaneous, pro-arrhythmic calcium signals disrupt electrical pacing in mouse pulmonary vein sleeve cells. PLoS One (2014) 0.88
Unique atrial myocyte Ca2+ signaling. J Mol Cell Cardiol (2008) 0.88
Ionic bases for electrical remodeling of the canine cardiac ventricle. Am J Physiol Heart Circ Physiol (2013) 0.87
Acute atrial arrhythmogenesis in murine hearts following enhanced extracellular Ca(2+) entry depends on intracellular Ca(2+) stores. Acta Physiol (Oxf) (2009) 0.87
Perturbed atrial calcium handling in an ovine model of heart failure: potential roles for reductions in the L-type calcium current. J Mol Cell Cardiol (2014) 0.86
Ablation of sarcolipin results in atrial remodeling. Am J Physiol Cell Physiol (2012) 0.86
Nonlinear and Stochastic Dynamics in the Heart. Phys Rep (2014) 0.86
Delayed afterdepolarizations generate both triggers and a vulnerable substrate promoting reentry in cardiac tissue. Heart Rhythm (2015) 0.85
Direct Evidence for Microdomain-Specific Localization and Remodeling of Functional L-Type Calcium Channels in Rat and Human Atrial Myocytes. Circulation (2015) 0.84
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation. Nat Rev Cardiol (2016) 0.83
Role of abnormal sarcoplasmic reticulum function in atrial fibrillation. Therapy (2010) 0.80
Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation. Cardiovasc Res (2013) 0.80
A Stochastic Individual-Based Model of the Progression of Atrial Fibrillation in Individuals and Populations. PLoS One (2016) 0.80
Calcium handling proteins: structure, function, and modulation by exercise. Heart Fail Rev (2014) 0.79
Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal. Cardiovasc Res (2016) 0.79
Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times? Cardiovasc Res (2009) 0.79
Pioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes. Med Sci Monit Basic Res (2014) 0.79
Atrial fibrillation complicated by heart failure induces distinct remodeling of calcium cycling proteins. PLoS One (2015) 0.79
A Dynamical Threshold for Cardiac Delayed Afterdepolarization-Mediated Triggered Activity. Biophys J (2016) 0.78
The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation. Arrhythm Electrophysiol Rev (2015) 0.78
Calcium signalling in developing cardiomyocytes: implications for model systems and disease. J Physiol (2015) 0.78
Atrial fibrillation in heart failure: steady progress but still a long way to go. Circ Arrhythm Electrophysiol (2008) 0.78
Persistence of pro-arrhythmic spatio-temporal calcium patterns in atrial myocytes: a computational study of ping waves. Front Physiol (2012) 0.77
Cellular Hypertrophy and Increased Susceptibility to Spontaneous Calcium-Release of Rat Left Atrial Myocytes Due to Elevated Afterload. PLoS One (2015) 0.77
Atrial myocyte function and Ca2+ handling is associated with inborn aerobic capacity. PLoS One (2013) 0.77
Imaging arrhythmogenic calcium signaling in intact hearts. Pediatr Cardiol (2012) 0.77
Aerobic interval training partly reverse contractile dysfunction and impaired Ca2+ handling in atrial myocytes from rats with post infarction heart failure. PLoS One (2013) 0.76
Looking into a conceptual framework of ROS-miRNA-atrial fibrillation. Int J Mol Sci (2014) 0.76
Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol (2015) 0.76
Diagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia? Biomed Res Int (2015) 0.76
Calcium-mediated cellular triggered activity in atrial fibrillation. J Physiol (2017) 0.75
Genotype influence in responses to therapy for atrial fibrillation. Expert Rev Cardiovasc Ther (2016) 0.75
Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure. Clin Med Insights Cardiol (2016) 0.75
SR calcium handling dysfunction, stress-response signaling pathways, and atrial fibrillation. Front Physiol (2015) 0.75
Serine/Threonine Phosphatases in Atrial Fibrillation. J Mol Cell Cardiol (2017) 0.75
Atrial SERCA2a Overexpression Has No Affect on Cardiac Alternans but Promotes Arrhythmogenic SR Ca2+ Triggers. PLoS One (2015) 0.75
Microvolt T-wave alternans in patients undergoing elective coronary artery bypass grafting: a pilot study. Heart Lung Vessel (2015) 0.75
Expression of connexin 43, ion channels and Ca(2+)-handling proteins in rat pulmonary vein cardiomyocytes. Exp Ther Med (2016) 0.75
Regulating the regulator: Insights into the cardiac protein phosphatase 1 interactome. J Mol Cell Cardiol (2016) 0.75
The involvement of TRPC3 channels in sinoatrial arrhythmias. Front Physiol (2015) 0.75
Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times. Korean Circ J (2017) 0.75
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res (2017) 0.75
Calcium Signaling and Cardiac Arrhythmias. Circ Res (2017) 0.75
Increased Ca buffering underpins remodelling of Ca(2+) handling in old sheep atrial myocytes. J Physiol (2017) 0.75
Icariin, a Novel Blocker of Sodium and Calcium Channels, Eliminates Early and Delayed Afterdepolarizations, As Well As Triggered Activity, in Rabbit Cardiomyocytes. Front Physiol (2017) 0.75
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet (2006) 6.39
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet (2009) 4.10
Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol (2008) 4.01
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80
Genome-wide association study of PR interval. Nat Genet (2010) 3.73
Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation (2010) 3.72
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J Clin Invest (2009) 3.45
Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol (2008) 3.26
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol (2012) 2.96
Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol (2007) 2.83
Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. J Am Coll Cardiol (2006) 2.73
A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol (2012) 2.71
Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation (2013) 2.66
Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation (2012) 2.58
Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J (2006) 2.54
Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest (2008) 2.54
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace (2009) 2.52
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc (2013) 2.47
Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest (2011) 2.38
Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J Am Coll Cardiol (2013) 2.38
Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve. Circulation (2008) 2.34
Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J (2012) 2.30
Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ Res (2005) 2.23
Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol (2009) 2.20
Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation (2005) 2.15
The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur Heart J (2008) 2.10
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res (2014) 2.07
Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res (2004) 2.06
Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm (2008) 2.05
Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model. Cardiovasc Res (2005) 2.02
Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res (2007) 2.02
Atrial fibrillation pathophysiology: implications for management. Circulation (2011) 2.01
Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res (2002) 2.00
Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am J Physiol Heart Circ Physiol (2002) 2.00
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation (2006) 2.00
Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J (2005) 1.96
Cardiac transgenic and gene transfer strategies converge to support an important role for troponin I in regulating relaxation in cardiac myocytes. Circ Res (2007) 1.95
Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Heart Rhythm (2012) 1.91
Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation (2010) 1.90
Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J (2007) 1.90
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet (2013) 1.86
Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res (2005) 1.86
Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation (2003) 1.86
Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol (2007) 1.85
Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation. Circ Res (2011) 1.82
Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation (2012) 1.81
Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol (2012) 1.81
Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev (2006) 1.80
Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation (2004) 1.77
Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res (2010) 1.74
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure. Heart Rhythm (2007) 1.71
Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J (2005) 1.71
Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes. J Am Coll Cardiol (2013) 1.68
Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res (2014) 1.68
Pulmonary vein reentry--properties and size matter: insights from a computational analysis. Heart Rhythm (2007) 1.68
Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest (2011) 1.68
Improved outcome following restoration of sinus rhythm prior to catheter ablation of persistent atrial fibrillation: a comparative multicenter study. Heart Rhythm (2012) 1.67
Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation (2005) 1.67
Genome-wide association analysis identifies multiple loci related to resting heart rate. Hum Mol Genet (2010) 1.67
Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium. Am J Physiol Heart Circ Physiol (2005) 1.65
New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet (2010) 1.65
Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation (2004) 1.64
Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts. Cardiovasc Res (2006) 1.62
Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation (2008) 1.61
Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors. Cardiovasc Res (2004) 1.60
Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm (2012) 1.59
Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability. Heart Rhythm (2010) 1.59
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet (2009) 1.59
Ca(2+)-related signaling and protein phosphorylation abnormalities play central roles in a new experimental model of electrical storm. Circulation (2011) 1.58
Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res (2009) 1.58
Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm (2010) 1.58
A proposal for new clinical concepts in the management of atrial fibrillation. Am Heart J (2012) 1.57
Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA). PLoS Med (2010) 1.56